Backers of a popular mobile app that claims to measure blood
pressure have reached a settlement with the Federal Trade Commission
following the revelation that its readings could be dangerously
inaccurate.The settlement comes as mobile health apps in general are
coming under increased scrutiny. Recent research, for example, found
that even the most highly-rated of these apps often failed to deliver
appropriate medical warnings when given potentially dangerous
information from users. It’s the reason that many believe there should
be increased communication between the FTC, Federal Drug Administration,
and software developers before apps are released to a trusting public.
Post a Comment